The presence of T lymphocytes within the tumor microenvironment, especially the cytotoxic CD8+ subsets and to some extent the CD4+ subsets, have been shown to correlate with better prognosis of the patient [21,22,23,24,25,26]. The gene discussed is CD4; the disease is neoplasm.